SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,251 | -68.2% | 47,100 | -31.0% | 0.00% | -100.0% |
| Q2 2023 | $88,790 | -35.3% | 68,300 | -12.4% | 0.00% | 0.0% |
| Q1 2023 | $137,280 | -44.0% | 78,000 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $245,000 | -55.9% | 78,100 | -31.2% | 0.00% | -60.0% |
| Q3 2022 | $556,000 | +26.9% | 113,500 | +7.4% | 0.01% | +25.0% |
| Q2 2022 | $438,000 | -28.0% | 105,700 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $608,000 | -23.3% | 104,700 | -0.9% | 0.00% | -20.0% |
| Q4 2021 | $793,000 | -31.1% | 105,700 | -17.2% | 0.01% | -37.5% |
| Q3 2021 | $1,151,000 | -25.0% | 127,700 | -0.4% | 0.01% | -33.3% |
| Q2 2021 | $1,535,000 | -4.4% | 128,200 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $1,606,000 | -21.9% | 128,200 | -2.8% | 0.02% | -25.0% |
| Q4 2020 | $2,057,000 | +60.2% | 131,845 | -2.9% | 0.02% | +42.9% |
| Q3 2020 | $1,284,000 | -5.1% | 135,845 | -10.1% | 0.01% | -12.5% |
| Q2 2020 | $1,353,000 | +17.4% | 151,045 | -16.5% | 0.02% | -5.9% |
| Q1 2020 | $1,152,000 | -2.5% | 180,790 | +28.0% | 0.02% | +30.8% |
| Q4 2019 | $1,182,000 | -74.2% | 141,275 | -66.7% | 0.01% | -76.4% |
| Q3 2019 | $4,575,000 | 0.0% | 424,801 | 0.0% | 0.06% | +1.9% |
| Q2 2019 | $4,575,000 | +595.3% | 424,801 | +516.3% | 0.05% | +575.0% |
| Q1 2019 | $658,000 | -15.7% | 68,925 | +1.3% | 0.01% | -27.3% |
| Q4 2018 | $781,000 | -72.7% | 68,025 | -59.8% | 0.01% | -66.7% |
| Q3 2018 | $2,866,000 | +207.5% | 169,110 | +157.8% | 0.03% | +200.0% |
| Q2 2018 | $932,000 | -99.9% | 65,600 | +0.2% | 0.01% | -26.7% |
| Q1 2018 | $1,244,500,000 | +51.8% | 65,500 | +31.0% | 0.02% | +50.0% |
| Q4 2017 | $820,000,000 | +9.3% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $750,000,000 | +70.5% | 50,000 | 0.0% | 0.01% | +66.7% |
| Q2 2017 | $440,000,000 | +188.5% | 50,000 | 0.0% | 0.01% | +200.0% |
| Q1 2017 | $152,500,000 | +100228.9% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $152,000 | -99.9% | 50,000 | -0.6% | 0.00% | -33.3% |
| Q3 2016 | $232,889,000 | -12.2% | 50,300 | +9.8% | 0.00% | -25.0% |
| Q2 2016 | $265,182,000 | -4.3% | 45,800 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $277,090,000 | -33.7% | 45,800 | 0.0% | 0.00% | -42.9% |
| Q4 2015 | $418,154,000 | +4.9% | 45,800 | -35.2% | 0.01% | 0.0% |
| Q3 2015 | $398,748,000 | -55.1% | 70,700 | -11.7% | 0.01% | -50.0% |
| Q2 2015 | $887,854,000 | -29.3% | 80,059 | 0.0% | 0.01% | -26.3% |
| Q1 2015 | $1,255,325,000 | – | 80,059 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |